Literature DB >> 8622433

Molecular evidence for transmission of hepatitis G virus by blood transfusion.

B Schmidt, K Korn, B Fleckenstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8622433     DOI： 10.1016/s0140-6736(96)91396-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Investigation of saliva, faeces, urine or semen samples for the presence of GBV-C RNA.

Authors:  Q R Eugenia; Q R Ana; M Carmen
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  Age-dependent acquisition of hepatitis G virus/GB virus C in a nonrisk population: detection of the virus by antibodies.

Authors:  H H Feucht; M Schröter; B Zöllner; S Polywka; R Laufs
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

3.  Molecular evidence of mother-to-infant transmission of hepatitis G virus among women without known risk factors for parenteral infections.

Authors:  C Menéndez; J M Sánchez-Tapias; P L Alonso; M Giménez-Barcons; E Kahigwa; J J Aponte; H Mshinda; M M Navia; M T Jiménez de Anta; J Rodés; J C Saiz
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

4.  Differential diagnosis of postoperative liver failure in a 12-year-old child.

Authors:  R Hausmann; B Schmidt; B Schellmann; P Betz
Journal:  Int J Legal Med       Date:  1996       Impact factor: 2.686

5.  Detection of GBV-C/HGV RNA in saliva and serum, but not in urine of infected patients.

Authors:  C A Seemayer; S Viazov; T Philipp; M Roggendorf
Journal:  Infection       Date:  1998 Jan-Feb       Impact factor: 3.553

6.  Hepatitis G virus infection in chronic liver disease.

Authors:  M Guilera; J C Sáiz; F X López-Labrador; E Olmedo; S Ampurdanés; X Forns; J Bruix; A Parés; J M Sánchez-Tapias; M T Jiménez de Anta; J Rodés
Journal:  Gut       Date:  1998-01       Impact factor: 23.059

7.  Prevalence of serum HGV-RNA among hemodialysis patients in Turkey.

Authors:  M Günaydin; A Bedir; T Akpolat; I Kuku; A Pekbay; S Esen; E Ozyilkan; N Arik; K Cengiz
Journal:  Infection       Date:  1997 Sep-Oct       Impact factor: 3.553

8.  GBV-C RNA presence in several high-risk groups of Spain.

Authors:  E Quirós; G Piédrola; M C Maroto
Journal:  Eur J Epidemiol       Date:  1998-09       Impact factor: 8.082

9.  Genotyping and infection rate of GBV-C among Iranian HCV- infected patients.

Authors:  Reza Ghanbari; Mehrdad Ravanshad; Seyed Younes Hosseini; Ramin Yaghobi; Kiana Shahzamani
Journal:  Hepat Mon       Date:  2010-06-01       Impact factor: 0.660
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.